Alexion Pharmaceuticals are investigating a possible new treatment for APS.
They are looking for people aged between 18-75 who have tested postive for antiphospholipid antibodies, and have at least one of the following signs or symptoms called “non-criteria manifestations" of APS:
APS-related kidney problems
APS-caused skin problems
Low platelet counts
There are a number of centres currently taking part in the trial across America, and in France and the UK.
In America the medical centres are located in New York, North Carolina, Texas and Virginia.
In France the hospital is based in Meurthe-et-Moselle.
In the UK the University College of London is taking part.
Travel assistance is available.
You can read more about the trial here: alexionclinicaltrials.com/a... and please contact Alexion at email@example.com if you have any questions and would like to take part.